Home › Targets › GSK-3β

GSK-3β (1 companies · 7 programs)

Companies with an active program directed at GSK-3β.

Actuate Therapeutics ACTU

Elraglusib Injection — Metastatic Pancreatic Ductal Adenocarcinoma Phase 2
Elraglusib Injection — Ewing Sarcoma Phase 1
Elraglusib Oral Tablet Phase 1
elraglusib — Metastatic Melanoma Phase 1
elraglusib — Non-Small Cell Lung Cancer Phase 1
elraglusib — Colorectal Cancer Phase 1
elraglusib — Pancreatic Ductal Adenocarcinoma Phase 1